Search

everythinglearnresearchcommunity

for

Search:↓

Androgens like testosterone increase colon muscle contractions by affecting calcium pathways.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Botulinum toxin may help treat hair loss but needs more research for effectiveness and cost concerns.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Activating δ-opioid receptors can help hair grow.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

TA-Ado effectively promotes hair growth and reduces hair loss.

Triptorelin helps evaluate hormone production in Sertoli-Leydig cell tumors.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

PPARα agonists may help treat alopecia areata by reducing inflammation.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Botulinum toxin may help treat male pattern baldness.

Botulinum toxin A may help regrow hair in pattern baldness.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

New A-homo-B, 19-dinor steroids showed strong antiandrogenic activity without affecting the enzyme 5α-reductase or androgen receptor binding.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Mutations at Val-889 and Arg-752 disrupt key interactions in androgen receptor dimerization.